Birch Allergy Treatment Market Snapshot

The global birch allergy treatment market garnered a market value of US$ 571 Million in 2023 and is expected to accumulate a market value of US$ 1123.24 Million by registering a CAGR of 7% in the forecast period 2023 to 2033. Growth of the birch allergy treatment market can be attributed to increasing prevalence of the ailment along with presence of treatment options for birch allergy. The market for birch allergy treatment registered a CAGR of 3.4% in the historical period 2016 to 2021

Birch allergy is an allergic reaction to the pollen of birch trees, which can cause symptoms such as sneezing, runny nose, itchy eyes, and skin rash. Treatment for birch allergy typically involves a combination of avoidance measures, medication, and immunotherapy.

Report Attribute Details
Expected Market Value (2023) US$ 571 Million
Anticipated Forecast Value (2033) US$ 1123.24 Million
Projected Growth Rate (2023 to 2033) 7% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Birch Allergy Treatment Market Demand Analysis vs. Forecast 2023 to 2033

According to market research and competitive intelligence provider Future Market Insights- the market for Birch allergy treatment reflected a value of 3.4% during the historical period, 2018 to 2022.

Increasing prevalence of allergies, rising healthcare expenditure, and advancements in allergy treatment technologies are driving the growth of the market. The birch allergy treatment market is expected to follow this trend and grow in tandem with the overall allergy treatment market. Treatment options for birch allergy, including immunotherapy and medication, are likely to continue to evolve and improve, providing better options for patients with birch allergy.

Thus, the market for Birch allergy treatment is expected to register a CAGR of 7% in the forecast period 2023 to 2033.

Which are Some Prominent Drivers of Birch Allergy Treatment Market?

Advancements in allergy treatment technologies boosting market growth

The incidence of allergies, including birch allergy, has been increasing globally in recent years. This trend is expected to continue, driving the demand for birch allergy treatment. The development of new and more effective treatments for allergies, including immunotherapy and biologic drugs, is driving the growth of the birch allergy treatment market.

Increasing healthcare expenditure, particularly in developing countries, is driving the growth of the healthcare sector, including the birch allergy treatment market. Governments are increasingly focusing on improving healthcare infrastructure and providing affordable healthcare to their citizens, which is expected to drive the growth of the birch allergy treatment market.

Increasing public awareness of allergies and the need for proper diagnosis and treatment is expected to drive the demand for birch allergy treatment. Overall, these drivers are expected to continue to fuel the growth of the birch allergy treatment market in the coming years.

Availability of different medications driving growth of Birch allergy treatment market

Medications: Over-the-counter antihistamines and decongestants can help relieve symptoms of birch allergy, such as sneezing, runny nose, and itchy eyes. For more severe cases, a doctor may prescribe stronger medications such as corticosteroids or immunomodulators.

Immunotherapy: Immunotherapy, also known as allergy shots, involves receiving injections or tablets containing gradually increasing doses of birch pollen to help build up tolerance to the allergen over time. This can provide long-term relief for birch allergy symptoms.

Sublingual immunotherapy (SLIT): SLIT is an alternative to allergy shots that involves placing a tablet or drops containing allergen extracts under the tongue. This method is less invasive than allergy shots but may not be as effective for all patients.

Emergency treatment: In rare cases, birch allergy can cause a severe allergic reaction called anaphylaxis, which requires emergency treatment with epinephrine.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the of Birch Allergy Treatment Market?

Side effects of treatment along with undiagnosed symptoms derailing market growth for Birch allergy

Birch allergy is often underdiagnosed and underreported, which can limit the demand for treatment and hinder market growth. Some birch allergy treatments, such as immunotherapy, can be expensive and may not be covered by insurance, making them less accessible to some patients.

Some birch allergy treatments, such as corticosteroids and immunomodulators, can have side effects and safety concerns that can limit their use or cause patients to seek alternative treatments. The development of alternative therapies, such as natural remedies and homeopathic treatments, can create competition for traditional birch allergy treatments and limit market growth.

The regulatory environment for birch allergy treatments can be complex and may vary by region, which can make it difficult for companies to bring new treatments to market.

Region-Wise Insights

High Prevalence of Birch Allergies Propelling Demand for Treatment in North America?

Availability of advanced healthcare infrastructure bolstering demand for Birch allergy treatment

The North America Birch allergy treatment market is driven by factors such as the increasing prevalence of allergies, rising healthcare expenditure, and the availability of advanced healthcare infrastructure in countries such as the United States and Canada. The growing prevalence of allergies, increasing demand for immunotherapy, and the availability of advanced healthcare infrastructure are driving the growth of the market in North America.

Additionally, the prevalence of birch allergy is relatively high in North America, particularly in regions with higher concentrations of birch trees. As such, there is a significant demand for birch allergy treatments, including immunotherapy, medications, and avoidance strategies, in this market.

Overall, the North America birch allergy treatment market is expected to continue to grow in the coming years, driven by the increasing prevalence of allergies and the development of new and more effective treatments. Thus, North America is expected to possess 48% market share for Birch allergy treatment market in 2023.

High Presence of Birch Trees in Europe Creating Lucrative Opportunities for Birch Allergy Treatment in Europe?

Availability of treatments and diagnostic tests driving market growth in Europe

The Europe Birch allergy treatment market is driven by factors such as the increasing prevalence of allergies, advancements in allergy treatment technologies, and rising healthcare expenditure in countries such as Germany, the United Kingdom, and France. Rising awareness of the need for proper diagnosis and treatment, and advancements in allergy treatment technologies are driving the growth of the market in Europe.

The prevalence of birch allergy is relatively high in Europe, particularly in countries with higher concentrations of birch trees, such as Finland, Sweden, and Norway. As such, there is a significant demand for birch allergy treatments, including immunotherapy, medications, and avoidance strategies, in this market. Thus, Europe is expected to possess 43% market share for Birch allergy treatment market in 2023.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-Wise Insights

Easier Accessibility to Orally Administered Medications Increasing Dependency on Oral Route of Administration?

Ongoing clinical trials for oral route of administration shaping landscape for birch allergy treatment

Oral administration of medications and immunotherapy has been shown to be effective in treating birch allergy. Oral medications such as antihistamines, decongestants, and corticosteroids can help alleviate symptoms of birch allergy such as sneezing, runny nose, and itchy eyes.

Sublingual immunotherapy (SLIT) is also an oral route of administration for allergy treatment that involves placing a tablet or drops containing allergen extracts under the tongue. SLIT has been shown to be effective in treating birch allergy and has the advantage of being less invasive than allergy shots.

In addition, there are ongoing clinical trials investigating the use of oral immunotherapy for birch allergy, which involves the ingestion of small amounts of birch pollen to gradually build up tolerance to the allergen. While still experimental, oral immunotherapy shows promise as a potential treatment option for birch allergy. Thus, oral route of administration is expected to possess 53% market share for Birch allergy treatment market in 2023.

Market Competition

Key players in the Birch allergy treatment market are Allergy Therapeutics Plc, Regeneron Pharmaceuticals Inc, Desentum, HAL Allergy Group, Roxall Medizin GmbH, Worg Pharmaceuticals AG, S-TARget therapeutics GmbH, Adamis Pharmaceuticals Corporation, Merck KGaA and Stallergenes Greer plc

  • Allergy Therapeutics has conducted clinical trials to evaluate the safety and efficacy of its immunotherapy products for the treatment of birch allergy. The company is committed to ongoing research and development to improve the effectiveness and accessibility of its treatments for patients with birch allergy.
  • Regeneron Pharmaceuticals Inc, a biopharmaceutical company has developed an investigational drug called REGN1908-1909 for the treatment of birch allergy. REGN1908-1909 is a combination of two monoclonal antibodies that target specific proteins involved in the allergic response to birch pollen. The drug works by blocking the activity of these proteins, reducing the severity of symptoms in patients with birch allergy.

Report Scope

Report Attribute Details
Market Value in 2023 US$ 571 Million
Market Value in 2033 US$ 1123.24 Million
Growth Rate CAGR of 5.2% from 2023 to 2033
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in USD Million and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
  • Drug Class
  • Route of Administration
  • Distribution Channel
  • Region
Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Mexico
  • Rest of Latin America
  • Germany
  • United kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
  • India
  • Malaysia
  • Singapore
  • Thailand
  • Rest of South Asia
  • China
  • Japan
  • South Korea
  • Austria
  • New Zealand
  • GCC countries
  • South Africa
  • Israel
  • Rest of MEA
Key Companies Profiled
  • Allergy Therapeutics Plc
  • Regeneron Pharmaceuticals Inc.
  • Desentum
  • HAL Allergy Group
  • Roxall Medizin GmbH
  • Worg Pharmaceuticals AG
  • S-TARget therapeutics GmbH
  • Adamis Pharmaceuticals Corporation
  • Merck KGaA
  • Stallergenes Greer plc
Customization Available Upon Request

Key Segments Profiled in the Birch Allergy Treatment Market Industry Survey

Drug Class:

  • Antihistamines
  • Cetirizine
  • Diphenhydramine
  • Decongestant
  • Pseudoephedrine
  • Oxymetazoline

Route of Administration:

  • Oral
  • Intranasal

Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

How Big is the Birch Allergy Treatment Market?

The market is valued at US$ 571 million in 2023.

What is the Growth Potential of the Birch Allergy Treatment Market?

The growth potential of the birch allergy treatment market is 7% CAGR through 2033.

Which Region Holds Dominance in Birch Allergy Treatment Market?

North America holds dominance in the global market.

What is the Top Trend Driving the Birch Allergy Treatment Market?

Technological advancements in allergy treatment may drive market growth over the coming years.

Who are the Key Birch Allergy Treatment Market Players?

Allergy Therapeutics Plc, Regeneron Pharmaceuticals Inc., and Desentum are key birch allergy treatment market players.

Table of Content

1. Executive Summary | Birch Allergy Treatment Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Drug Class, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drug Class, 2023 to 2033

        5.3.1. Antihistamines

        5.3.2. Cetirizine

        5.3.3. Diphenhydramine

        5.3.4. Decongestant

        5.3.5. Pseudoephedrine

        5.3.6. Oxymetazoline

    5.4. Y-o-Y Growth Trend Analysis By Drug Class, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Drug Class, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033

        6.3.1. Oral

        6.3.2. Intranasal

    6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel , 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel , 2023 to 2033

        7.3.1. Hospital Pharmacy

        7.3.2. Online Pharmacy

        7.3.3. Retail Pharmacy

    7.4. Y-o-Y Growth Trend Analysis By Distribution Channel , 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Distribution Channel , 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Drug Class

        9.2.3. By Route of Administration

        9.2.4. By Distribution Channel

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Drug Class

        9.3.3. By Route of Administration

        9.3.4. By Distribution Channel

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Drug Class

        10.2.3. By Route of Administration

        10.2.4. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Drug Class

        10.3.3. By Route of Administration

        10.3.4. By Distribution Channel

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Drug Class

        11.2.3. By Route of Administration

        11.2.4. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drug Class

        11.3.3. By Route of Administration

        11.3.4. By Distribution Channel

    11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Drug Class

        12.2.3. By Route of Administration

        12.2.4. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drug Class

        12.3.3. By Route of Administration

        12.3.4. By Distribution Channel

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Drug Class

        13.2.3. By Route of Administration

        13.2.4. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drug Class

        13.3.3. By Route of Administration

        13.3.4. By Distribution Channel

    13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Drug Class

        14.2.3. By Route of Administration

        14.2.4. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drug Class

        14.3.3. By Route of Administration

        14.3.4. By Distribution Channel

    14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Drug Class

        15.2.3. By Route of Administration

        15.2.4. By Distribution Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Drug Class

        15.3.3. By Route of Administration

        15.3.4. By Distribution Channel

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Drug Class

            16.1.2.2. By Route of Administration

            16.1.2.3. By Distribution Channel

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Drug Class

            16.2.2.2. By Route of Administration

            16.2.2.3. By Distribution Channel

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Drug Class

            16.3.2.2. By Route of Administration

            16.3.2.3. By Distribution Channel

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Drug Class

            16.4.2.2. By Route of Administration

            16.4.2.3. By Distribution Channel

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Drug Class

            16.5.2.2. By Route of Administration

            16.5.2.3. By Distribution Channel

    16.6. United kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Drug Class

            16.6.2.2. By Route of Administration

            16.6.2.3. By Distribution Channel

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Drug Class

            16.7.2.2. By Route of Administration

            16.7.2.3. By Distribution Channel

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Drug Class

            16.8.2.2. By Route of Administration

            16.8.2.3. By Distribution Channel

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Drug Class

            16.9.2.2. By Route of Administration

            16.9.2.3. By Distribution Channel

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Drug Class

            16.10.2.2. By Route of Administration

            16.10.2.3. By Distribution Channel

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Drug Class

            16.11.2.2. By Route of Administration

            16.11.2.3. By Distribution Channel ;

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Drug Class

            16.12.2.2. By Route of Administration

            16.12.2.3. By Distribution Channel

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Drug Class

            16.13.2.2. By Route of Administration

            16.13.2.3. By Distribution Channel

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Drug Class

            16.14.2.2. By Route of Administration

            16.14.2.3. By Distribution Channel

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Drug Class

            16.15.2.2. By Route of Administration

            16.15.2.3. By Distribution Channel

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Drug Class

            16.16.2.2. By Route of Administration

            16.16.2.3. By Distribution Channel

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Drug Class

            16.17.2.2. By Route of Administration

            16.17.2.3. By Distribution Channel

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Drug Class

            16.18.2.2. By Route of Administration

            16.18.2.3. By Distribution Channel

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Drug Class

            16.19.2.2. By Route of Administration

            16.19.2.3. By Distribution Channel

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Drug Class

            16.20.2.2. By Route of Administration

            16.20.2.3. By Distribution Channel

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Drug Class

            16.21.2.2. By Route of Administration

            16.21.2.3. By Distribution Channel

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Drug Class

        17.3.3. By Route of Administration

        17.3.4. By Distribution Channel

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Allergy Therapeutics Plc

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Regeneron Pharmaceuticals Inc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Desentum

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. HAL Allergy Group

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Roxall Medizin GmbH

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Worg Pharmaceuticals AG

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. S-TARget therapeutics GmbH

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Adamis Pharmaceuticals Corporation

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Merck KGaA

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Stallergenes Greer plc

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Birch Allergy Treatment Market

Schedule a Call